Document ID: chunk:federal_register_of_legislation:F2023L01747:schedule:1:p12
Version: federal_register_of_legislation:F2023L01747
Segment Type: schedule
Provision Reference: sch 1 (pt 12/31)
Character Range: 38273–42130

Schedule 1, Part 1, entry for Ibrutinib in the form Capsule 140 mg [Maximum Quantity: 120; Number of Repeats: 5]
         (a)           omit from the column headed "Circumstances": C14344
         (b)           insert in numerical order in the column headed "Circumstances": C14788

     [57]               Schedule 1, Part 1, entry for Ipratropium in each of the forms: Nebuliser solution containing ipratropium bromide 250 micrograms (as monohydrate) in 1 mL single dose units, 30; and Nebuliser solution containing ipratropium bromide 500 micrograms (as monohydrate) in 1 mL single dose units, 30
     omit:
         a  APO-Ipratropium  TX  MP NP  C6331 C6341     2  5  1

     [58]               Schedule 1, Part 1, entry for Lamotrigine in each of the forms: Tablet 25 mg; Tablet 50 mg; Tablet 100 mg; and Tablet 200 mg
     omit:
         a  APO-Lamotrigine  TX  MP NP  C11081     56  5  56

     [59]               Schedule 1, Part 1, entry for Levonorgestrel with ethinylestradiol in the form Pack containing 21 tablets 150 micrograms-30 micrograms and 7 inert tablets
     omit:
            Monofeme 28   FZ   MP NP         4   2   4

     [60]               Schedule 1, Part 1, entry for Lumacaftor with ivacaftor
     insert as first entry:
   Sachet containing granules, lumacaftor 75 mg and ivacaftor 94 mg  Oral     Orkambi  VR  MP  See Note 3  See Note 3  See Note 3  See Note 3  56     D(100)

     [61]               Schedule 1, Part 1, entry for Lumacaftor with ivacaftor in each of the forms: Tablet containing lumacaftor 100 mg with ivacaftor 125 mg; and Tablet containing lumacaftor 200 mg with ivacaftor 125 mg
     insert in the column headed "Purposes": See Note 3

     [62]               Schedule 1, Part 1, entry for Metformin in the form Tablet (extended release) containing metformin hydrochloride 500 mg
     omit:
         a  Metformin XR 500 APOTEX  GX  MP NP        120  5  120

     [63]               Schedule 1, Part 1, entry for Metformin in the form Tablet containing metformin hydrochloride 500 mg
     omit:
         a  APO-Metformin 500  TX  MP NP        100  5  100

     [64]               Schedule 1, Part 1, entry for Metformin in the form Tablet containing metformin hydrochloride 850 mg
     omit:
         a  APO-Metformin 850  TX  MP NP        60  5  60

     [65]               Schedule 1, Part 1, entry for Metformin in the form Tablet containing metformin hydrochloride 1 g
     omit:
         a  APO-Metformin 1000  TX  MP NP        90  5  90

     [66]               Schedule 1, Part 1, entry for Metoclopramide in the form Injection containing 10 mg metoclopramide hydrochloride (as monohydrate) in 2 mL
     substitute:
Metoclopramide  Injection containing 10 mg metoclopramide hydrochloride (as monohydrate) in 2 mL  Injection  a  Maxolon                      IL  MP NP MW PDP            10      0       10
                                                                                                             a  METOCLOPRAMIDE INJECTION BP  WZ  MP NP MW PDP            10      0       10
                                                                                                             a  Maxolon                      IL  MP NP            P6084  40      2       10
                                                                                                                                                                         CN6084  CN6084
                                                                                                             a  METOCLOPRAMIDE INJECTION BP  WZ  MP NP            P6084  40      2       10
                                                                                                                                                                         CN6084  CN6084

     [67]               Schedule 1, Part 1, entry